×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Legionella Testing Market

ID: MRFR/HC/31203-HCR
128 Pages
Rahul Gotadki
October 2025

Legionella Testing Market Research Report By Test Type (Culture Tests, Polymerase Chain Reaction, Antigen Detection Tests, Nucleic Acid Amplification Tests), By Technology (Traditional Methods, Molecular Methods, Immunological Methods), By Sample Type (Water Samples, Environmental Samples, Clinical Samples), By End User (Hospitals, Laboratories, Public Health Organizations, Research Institutions) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Legionella Testing Market Infographic
Purchase Options

Legionella Testing Market Summary

As per MRFR analysis, the Legionella Testing Market Size was estimated at 0.83 USD Billion in 2024. The Legionella Testing industry is projected to grow from 0.8743 in 2025 to 1.471 by 2035, exhibiting a compound annual growth rate (CAGR) of 5.34 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Legionella Testing Market is experiencing robust growth driven by regulatory demands and technological advancements.

  • North America remains the largest market for Legionella testing, driven by stringent regulatory requirements.
  • The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing public health awareness.
  • Culture tests continue to dominate the market, while polymerase chain reaction methods are gaining traction as the fastest-growing segment.
  • Increased regulatory compliance and rising public health concerns are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 0.83 (USD Billion)
2035 Market Size 1.471 (USD Billion)
CAGR (2025 - 2035) 5.34%

Major Players

Thermo Fisher Scientific (US), Merck KGaA (DE), Hach Company (US), Eurofins Scientific (LU), SGS SA (CH), Bureau Veritas (FR), Intertek Group plc (GB), Pace Analytical Services, LLC (US), ALS Limited (AU)

Legionella Testing Market Trends

The Legionella Testing Market is currently experiencing a notable evolution, driven by heightened awareness regarding waterborne pathogens and their potential health implications. Regulatory bodies are increasingly mandating stringent testing protocols, which has led to a surge in demand for reliable testing solutions. This market appears to be characterized by a diverse array of testing methodologies, including culture-based techniques, polymerase chain reaction (PCR), and immunological assays. As organizations strive to ensure safe water quality, the emphasis on rapid and accurate testing methods is becoming more pronounced. Moreover, the growing trend of environmental sustainability is influencing the Legionella Testing Market. Companies are increasingly adopting eco-friendly practices, which may include the development of greener testing kits and methodologies. This shift not only aligns with global sustainability goals but also caters to a more environmentally conscious consumer base. As the market continues to evolve, it seems likely that innovation will play a crucial role in shaping future testing solutions, ensuring they meet both regulatory requirements and consumer expectations.

Increased Regulatory Scrutiny

The landscape of the Legionella Testing Market is being shaped by heightened regulatory scrutiny. Authorities are implementing more rigorous testing requirements to safeguard public health, which is driving demand for advanced testing solutions. Organizations are compelled to comply with these regulations, leading to an uptick in testing frequency and the adoption of more sophisticated methodologies.

Technological Advancements

Technological advancements are significantly influencing the Legionella Testing Market. Innovations in testing technologies, such as rapid detection methods and automation, are enhancing the efficiency and accuracy of testing processes. These developments not only streamline operations but also provide quicker results, which is essential for effective water management.

Growing Awareness and Education

There is a noticeable increase in awareness and education surrounding Legionella risks. Public health campaigns and educational initiatives are informing stakeholders about the dangers of Legionella bacteria. This growing awareness is likely to drive demand for testing services, as organizations seek to mitigate risks associated with waterborne pathogens.

Legionella Testing Market Drivers

Rising Public Health Concerns

Public health concerns regarding waterborne diseases are driving the Legionella Testing Market. With increasing awareness of the health risks associated with Legionella bacteria, there is a growing emphasis on preventive measures in both residential and commercial settings. Reports indicate that Legionnaires disease cases have been on the rise, prompting health authorities to advocate for regular testing of water systems. This heightened awareness is likely to lead to increased investments in Legionella testing services, as organizations aim to safeguard public health and comply with emerging health guidelines. Consequently, the market is poised for growth as stakeholders recognize the importance of proactive testing in mitigating health risks.

Increased Regulatory Compliance

The Legionella Testing Market is experiencing heightened regulatory compliance requirements across various sectors, particularly in healthcare and hospitality. Governments and health organizations are implementing stringent guidelines to ensure water safety and prevent outbreaks of Legionnaires disease. For instance, regulations may mandate routine testing of water systems in large buildings, which drives demand for Legionella testing services. The market is projected to grow as organizations seek to comply with these regulations, with estimates suggesting a compound annual growth rate of around 8% over the next few years. This regulatory landscape compels facilities to invest in reliable testing solutions, thereby expanding the Legionella Testing Market.

Technological Innovations in Testing

Technological advancements are significantly influencing the Legionella Testing Market. Innovations such as rapid testing methods and automated sampling systems are enhancing the efficiency and accuracy of Legionella detection. For example, the introduction of PCR-based testing techniques allows for quicker results, which is crucial for timely interventions. The market is likely to see an increase in the adoption of these advanced technologies, as they not only improve testing turnaround times but also reduce labor costs associated with traditional methods. As organizations prioritize effective water management strategies, the demand for innovative testing solutions is expected to rise, further propelling the Legionella Testing Market.

Increased Investment in Infrastructure

Increased investment in infrastructure, particularly in aging water systems, is significantly impacting the Legionella Testing Market. Many regions are facing challenges related to outdated plumbing and water distribution systems, which can harbor Legionella bacteria. As governments and private entities allocate funds for infrastructure upgrades, there is a growing need for effective testing solutions to ensure water safety. This investment trend is likely to drive demand for Legionella testing services, as stakeholders seek to mitigate risks associated with legacy systems. The market may witness substantial growth as infrastructure improvements necessitate enhanced testing protocols to protect public health and comply with regulatory standards.

Expansion of Water Management Practices

The expansion of water management practices across various industries is a key driver for the Legionella Testing Market. As organizations increasingly recognize the importance of maintaining water quality, there is a corresponding rise in the implementation of comprehensive water management programs. These programs often include regular Legionella testing as a critical component to ensure safe water systems. Industries such as healthcare, hospitality, and manufacturing are particularly focused on enhancing their water management protocols, which is likely to result in a surge in demand for Legionella testing services. This trend indicates a robust growth trajectory for the Legionella Testing Market as more entities prioritize water safety.

Market Segment Insights

By Test Type: Culture Tests (Largest) vs. Polymerase Chain Reaction (Fastest-Growing)

The Legionella Testing Market reveals a diverse distribution of test types across its segments, with Culture Tests holding the largest market share. These traditional methods benefit from utilization in laboratories where accuracy and reliability are paramount. On the other hand, Polymerase Chain Reaction (PCR) tests are rapidly gaining traction, indicating a shift towards more advanced molecular testing techniques. The growing preference for rapid and sensitive detection methods is reshaping market dynamics.

Testing Techniques: Culture Tests (Dominant) vs. Nucleic Acid Amplification Tests (Emerging)

Culture Tests remain the dominant players in the Legionella Testing Market, known for their high specificity and ability to grow the Legionella bacteria for accurate identification. They are particularly favored in clinical settings due to their time-tested efficacy and regulatory approval. Conversely, Nucleic Acid Amplification Tests (NAATs) are emerging as the next frontier, leveraging cutting-edge technology to provide faster results with higher sensitivity. As regulatory approvals increase and healthcare facilities seek efficient testing solutions, NAATs are expected to carve out a significant niche, indicating a transition towards more rapid diagnostic methods.

By Technology: Traditional Methods (Largest) vs. Molecular Methods (Fastest-Growing)

In the Legionella Testing Market, the share of technology segments is diversifying, with Traditional Methods occupying the largest market share. These methods, including culture-based techniques, remain preferred due to their established reliability among laboratories. The stability of these techniques underpins their dominance, appealing to sectors that value proven methodologies in water quality testing. Conversely, Molecular Methods are rapidly emerging as the fastest-growing segment due to their superior capability for rapid detection and specificity. The increasing demand for faster testing results in various environments, including hospitals and public water systems, drives this growth. The adoption of advanced techniques highlights a shift in market preferences towards efficiency, indicating a promising trajectory for future development in Legionella testing protocols.

Technology: Traditional Methods (Dominant) vs. Molecular Methods (Emerging)

Traditional Methods, such as culture and biochemical assays, deliver reliable results with a longer history of use in the testing of Legionella. These techniques require time and specific conditions to cultivate the organism, which while time-consuming, assures thorough accuracy in detection. On the other hand, Molecular Methods leverage PCR (Polymerase Chain Reaction) and other nucleic acid amplification technologies to provide rapid and sensitive detection of Legionella species. This transition showcases a significant trend towards embracing faster and more efficient approaches in testing, with Molecular Methods appealing to sectors needing quick analysis like the healthcare and industry, positioning them as a key player in the evolving landscape of Legionella testing.

By Sample Type: Water Samples (Largest) vs. Environmental Samples (Fastest-Growing)

In the Legionella Testing Market, the sample type segment is prominently led by water samples, which account for the largest share due to their pivotal role in public health monitoring. Following water samples, environmental samples have emerged as the fastest-growing category, reflecting an increasing emphasis on comprehensive environmental assessments to prevent Legionella outbreaks. Clinical samples, while critical, occupy a smaller portion of the market, focusing mainly on disease diagnosis and management.

Water Samples (Dominant) vs. Environmental Samples (Emerging)

Water samples hold a dominant position in the Legionella Testing Market, primarily because of the high volume of testing required in water supply systems and recreational water bodies. Their importance is underscored by regulatory mandates and public health initiatives targeting Legionella prevention. On the other hand, environmental samples are gaining traction as emerging players in the market, driven by a growing awareness of the health risks associated with Legionella in diverse environments, such as cooling towers and industrial systems. This shift reflects an evolving landscape in legionella testing, driven by both regulatory changes and a broader understanding of environmental health.

By End User: Hospitals (Largest) vs. Laboratories (Fastest-Growing)

In the Legionella Testing Market, hospitals command the largest share as they prioritize preventative measures against outbreaks in healthcare settings. They are required to maintain strict compliance with safety regulations, making reliable testing essential. Laboratories play a crucial role as well, contributing significantly to the overall market due to their extensive testing capabilities and partnerships with healthcare institutions. Their demand continues to rise as the importance of accurate and rapid testing becomes more recognized in managing public health risks.

Laboratories: Fastest-Growing vs. Public Health Organizations: Dominant

Laboratories represent the fastest-growing segment within the Legionella Testing Market as they expand their technological capabilities and service offerings to meet increasing demand. Their agility in adopting new testing methods allows them to serve diverse clientele, including hospitals and public health organizations. On the other hand, public health organizations remain a dominant force, focusing on regulatory compliance and public safety through effective monitoring and response strategies. This segment benefits from increased government funding and public awareness initiatives to enhance testing capacity in response to Legionella risks.

Get more detailed insights about Legionella Testing Market

Regional Insights

North America : Regulatory Leader in Testing

North America is the largest market for Legionella testing, accounting for approximately 45% of the global share. The region's growth is driven by stringent regulations regarding water quality and public health, particularly in the U.S. and Canada. Increased awareness of Legionnaires' disease and its health implications has led to a surge in demand for testing services. Regulatory bodies like the EPA have implemented guidelines that further catalyze market growth. The U.S. is the leading country in this market, with significant contributions from key players such as Thermo Fisher Scientific and Hach Company. Canada follows as the second-largest market, focusing on compliance with health regulations. The competitive landscape is characterized by a mix of established companies and emerging players, all striving to innovate and meet the growing demand for reliable testing solutions.

Europe : Emerging Regulatory Frameworks

Europe is witnessing a growing demand for Legionella testing, holding approximately 30% of the global market share. The region's growth is fueled by increasing regulatory frameworks aimed at ensuring water safety and public health. Countries like Germany and France are at the forefront, implementing stringent testing protocols to combat Legionnaires' disease outbreaks. The European Union's directives on water quality are significant catalysts for market expansion. Germany leads the European market, followed closely by France and the UK. The competitive landscape features major players like Merck KGaA and Eurofins Scientific, who are investing in advanced testing technologies. The presence of these key players enhances the market's robustness, as they strive to meet the evolving regulatory requirements and consumer demands for effective testing solutions.

Asia-Pacific : Rapid Growth in Testing Services

Asia-Pacific is rapidly emerging as a significant player in the Legionella testing market, accounting for about 20% of the global share. The region's growth is driven by increasing industrialization, urbanization, and rising awareness of waterborne diseases. Countries like Australia and Japan are leading the charge, with regulatory bodies emphasizing the importance of water quality testing to prevent outbreaks of Legionnaires' disease. Australia is the largest market in the region, with Japan following closely. The competitive landscape is evolving, with both local and international players like ALS Limited and SGS SA expanding their presence. The demand for innovative testing solutions is on the rise, as stakeholders seek to comply with emerging regulations and ensure public health safety in rapidly urbanizing areas.

Middle East and Africa : Growing Awareness and Regulation

The Middle East and Africa region is gradually recognizing the importance of Legionella testing, holding about 5% of the global market share. The growth is primarily driven by increasing awareness of water quality issues and the health risks associated with Legionnaires' disease. Countries like South Africa and the UAE are beginning to implement regulations that mandate testing in public facilities, which is expected to boost market demand significantly. South Africa is currently the leading market in this region, with the UAE showing promising growth potential. The competitive landscape is still developing, with a mix of local and international players entering the market. Companies are focusing on establishing partnerships and enhancing their service offerings to meet the growing regulatory requirements and consumer awareness regarding water safety.

Legionella Testing Market Regional Image

Key Players and Competitive Insights

The Legionella Testing Market is characterized by a dynamic competitive landscape, driven by increasing regulatory scrutiny and heightened awareness of public health. Key players are actively engaging in strategies that emphasize innovation, regional expansion, and partnerships to enhance their market positioning. Companies such as Thermo Fisher Scientific (US), Merck KGaA (DE), and Hach Company (US) are at the forefront, leveraging their technological capabilities to develop advanced testing solutions. This collective focus on innovation and strategic collaborations is shaping a competitive environment that is increasingly responsive to emerging health concerns and regulatory requirements.

In terms of business tactics, companies are localizing manufacturing and optimizing supply chains to enhance operational efficiency and reduce lead times. The market appears moderately fragmented, with several key players exerting influence over specific regions. This fragmentation allows for niche players to thrive, while larger companies consolidate their positions through strategic acquisitions and partnerships. The interplay between these tactics and the competitive structure fosters a landscape where agility and responsiveness are paramount.

In August 2025, Thermo Fisher Scientific (US) announced the launch of a new rapid testing kit designed for Legionella detection in water systems. This innovation is significant as it addresses the urgent need for timely testing solutions in various industries, including healthcare and hospitality. By enhancing the speed and accuracy of testing, Thermo Fisher aims to solidify its market leadership and respond effectively to growing regulatory demands.

In July 2025, Merck KGaA (DE) expanded its portfolio by acquiring a small biotech firm specializing in environmental testing technologies. This strategic move is indicative of Merck's commitment to enhancing its capabilities in the Legionella testing domain. The acquisition not only broadens its product offerings but also positions the company to leverage cutting-edge technologies that could redefine testing methodologies in the future.

In September 2025, Hach Company (US) entered into a partnership with a leading water management firm to integrate its testing solutions into smart water management systems. This collaboration is pivotal as it aligns with the growing trend of digitalization in water quality monitoring. By embedding its testing technologies within smart systems, Hach is likely to enhance its market reach and provide comprehensive solutions that meet the evolving needs of customers.

As of October 2025, the competitive trends in the Legionella Testing Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, enabling companies to pool resources and expertise to address complex challenges. Looking ahead, competitive differentiation is expected to evolve, shifting from traditional price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition underscores the importance of agility and responsiveness in a market that is becoming ever more interconnected and complex.

Key Companies in the Legionella Testing Market market include

Industry Developments

  • Q2 2024: IDEXX Launches Legiolert Test for Rapid Detection of Legionella pneumophila in Water IDEXX announced the launch of its Legiolert test, designed to rapidly detect Legionella pneumophila in water samples, aiming to improve public health safety and compliance with water testing regulations.
  • Q1 2024: QuidelOrtho Corporation Receives CE Mark for Sofia Legionella FIA Test QuidelOrtho Corporation received CE Mark approval for its Sofia Legionella FIA test, enabling the company to market the product in the European Union for rapid detection of Legionella antigens in clinical samples.
  • Q2 2024: Thermo Fisher Scientific Expands Legionella Testing Market Portfolio with New PCR Assay Thermo Fisher Scientific announced the expansion of its Legionella testing portfolio by launching a new PCR assay, designed to provide faster and more accurate detection of Legionella species in water systems.
  • Q2 2024: Bio-Rad Laboratories Announces Partnership with European Water Utility for Legionella Monitoring Bio-Rad Laboratories entered into a partnership with a major European water utility to supply Legionella testing kits and support ongoing monitoring programs to prevent outbreaks in municipal water systems.
  • Q1 2024: Qiagen Launches New Automated Legionella Testing Market Platform Qiagen launched a new automated platform for Legionella testing, aiming to streamline laboratory workflows and improve the speed and reliability of Legionella detection in environmental samples.
  • Q2 2024: Eiken Chemical Co., Ltd. Announces Expansion of Legionella Test Production Facility in Japan Eiken Chemical Co., Ltd. announced the opening of an expanded production facility in Japan dedicated to manufacturing Legionella test kits, responding to increased demand for water safety testing.
  • Q1 2025: Pro-Lab Diagnostics Receives UK Regulatory Approval for New Legionella Rapid Test Pro-Lab Diagnostics received regulatory approval in the UK for its new rapid Legionella test, allowing the company to market the product to healthcare and environmental testing laboratories.
  • Q2 2025: Abbott Laboratories Launches Next-Generation Legionella Detection System Abbott Laboratories launched a next-generation Legionella detection system, featuring enhanced sensitivity and faster turnaround times for water testing in commercial and healthcare settings.
  • Q1 2025: QuidelOrtho Corporation Announces Strategic Partnership with US Hospital Network for Legionella Surveillance QuidelOrtho Corporation announced a strategic partnership with a large US hospital network to implement Legionella surveillance programs using its diagnostic products.
  • Q2 2024: Thermo Fisher Scientific Acquires Small Diagnostics Firm Specializing in Legionella Testing Market Thermo Fisher Scientific completed the acquisition of a diagnostics firm specializing in Legionella testing, aiming to strengthen its position in the waterborne pathogen detection market.
  • Q1 2024: IDEXX Receives US EPA Approval for Legiolert Test Method IDEXX received approval from the US Environmental Protection Agency (EPA) for its Legiolert test method, allowing its use in official water quality monitoring programs.
  • Q2 2025: Bio-Rad Laboratories Announces $20 Million Investment to Expand Legionella R&D Bio-Rad Laboratories announced a $20 million investment to expand research and development efforts focused on new Legionella detection technologies and products.

Future Outlook

Legionella Testing Market Future Outlook

The Legionella Testing Market is projected to grow at a 5.34% CAGR from 2024 to 2035, driven by increasing regulatory requirements and heightened public health awareness.

New opportunities lie in:

  • Development of rapid testing kits for on-site analysis
  • Expansion of digital platforms for remote testing services
  • Partnerships with healthcare facilities for integrated testing solutions

By 2035, the market is expected to be robust, driven by innovation and strategic partnerships.

Market Segmentation

Legionella Testing Market End User Outlook

  • Hospitals
  • Laboratories
  • Public Health Organizations
  • Research Institutions

Legionella Testing Market Test Type Outlook

  • Culture Tests
  • Polymerase Chain Reaction
  • Antigen Detection Tests
  • Nucleic Acid Amplification Tests

Legionella Testing Market Technology Outlook

  • Traditional Methods
  • Molecular Methods
  • Immunological Methods

Legionella Testing Market Sample Type Outlook

  • Water Samples
  • Environmental Samples
  • Clinical Samples

Report Scope

MARKET SIZE 20240.83(USD Billion)
MARKET SIZE 20250.8743(USD Billion)
MARKET SIZE 20351.471(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)5.34% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Billion
Key Companies ProfiledMarket analysis in progress
Segments CoveredMarket segmentation analysis in progress
Key Market OpportunitiesAdvancements in rapid testing technologies enhance detection capabilities in the Legionella Testing Market.
Key Market DynamicsRising regulatory scrutiny and technological advancements drive demand for efficient Legionella testing solutions across various sectors.
Countries CoveredNorth America, Europe, APAC, South America, MEA

Leave a Comment

FAQs

What is the current valuation of the Legionella Testing Market as of 2024?

The Legionella Testing Market was valued at 0.83 USD Billion in 2024.

What is the projected market size for the Legionella Testing Market in 2035?

The market is projected to reach 1.471 USD Billion by 2035.

What is the expected CAGR for the Legionella Testing Market during the forecast period 2025 - 2035?

The expected CAGR for the Legionella Testing Market during 2025 - 2035 is 5.34%.

Which test types are included in the Legionella Testing Market segments?

The test types include Culture Tests, Polymerase Chain Reaction, Antigen Detection Tests, and Nucleic Acid Amplification Tests.

What are the projected valuations for Culture Tests and Polymerase Chain Reaction in 2035?

Culture Tests are projected to reach between 0.45 and 0.65 USD Billion, while Polymerase Chain Reaction may reach between 0.35 and 0.55 USD Billion by 2035.

How do the different technologies in the Legionella Testing Market compare in terms of valuation?

Molecular Methods are expected to have the highest valuation, projected between 0.35 and 0.65 USD Billion, compared to Traditional and Immunological Methods.

What types of samples are analyzed in the Legionella Testing Market?

The market analyzes Water Samples, Environmental Samples, and Clinical Samples.

What is the projected valuation for Environmental Samples in 2035?

Environmental Samples are projected to reach between 0.55 and 0.75 USD Billion by 2035.

Who are the key players in the Legionella Testing Market?

Key players include Thermo Fisher Scientific, Merck KGaA, Hach Company, Eurofins Scientific, and SGS SA.

Which end users are driving demand in the Legionella Testing Market?

End users include Hospitals, Laboratories, Public Health Organizations, and Research Institutions.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions